On December 25, 2020, Professor Evans from University of Manchester, UK took the post as Honorary Editor-in-Chief of Journal of Translational Genetics and Genomics (JTGG). He will contribute a high-quality article to the ongoing special issue "Genetics and Epigenetics in Obesity Associated Cancers" organized by one of our associate editors, Professor Nathan A. Berger from Case Western Reserve University.
Professor Evans has established a reputation at home and abroad in clinical and research aspects of cancer genetics, particularly in neurofibromatosis and breast or colorectal cancer. He has published 864 peer reviewed research publications and over 150 reviews and chapters. In addition, he has had a book published by Oxford University Press on familial cancer (a total of 1015 publications). He has an ISI web of knowledge with an H-index of 116 and google scholar of 152. In the last 8 years, he has raised over £50 million in grants for multicenter and local studies-approximately £42 million to Manchester. He is chief investigator on two NIHR program grants (2009-2014-£1.59 million) (2017-2020-£1million) on breast cancer risk prediction and also has an NIHR RfPB grant as CI (2011). He has led a successful bid for a nationally-funded NF2 service (£7.5 million pa) that started in 2010 and is involved in the national complex NF1 service. He is a leading clinician on the NICE familial breast cancer guideline group, who recently has become a trustee of Breast Cancer Now and the Neuro Foundation. He is on the Editorial Board of JNCI and several other journals. He is the recipient of a number of awards including the Theodor Schwann, von Recklinghausen and Sir Patrick Forrest Prize twice. In 2020, he was made a fellow of the learned society of Wales (FLSW) and of the Royal College of Obstetrics and Gynaecology (FRCOG ad eundem).
We believe that JTGG will develop better and better with the participation of Professor Evans and the joint efforts of Editorial Board members.